Article
In utero and postnatal VX-770 administration rescues multiorgan disease in a ferret model of cystic fibrosis
27 Mar 2019
Abstract excerpt
animals showed the greatest VX-770-mediated protection from these pathologies. Sustained postnatal VX-770 administration led to improved pancreatic exocrine function, glucose tolerance, growth and survival, and to reduced mucus accumulation and bacterial infections in the lung. VX-770 withdrawal at any age reestablished disease, with the most rapid onset of morbidity occurring when withdrawal was initiated during...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
